Among the different stages of breast cancer, in general, stages III and IV showed reduced mdig expression relative to stages I and II breast cancers, suggesting a loss of mdig expression in later-stage breast cancers (Fig. 6h). This evidence concerns the gene RIOX2 and breast carcinoma.